11. 2-{[(1H-Indol-3-yl)methyl](methyl)amino}-1-(3-methoxyphenyl)ethanol hydrogen oxalate (7d). Light
pink powder, yield 69%, mp 68–72 °C (with slow decomposition). IR (ATR): 3304, 3114, 3052, 2963,
2838, 1715, 1600, 1487, 1456, 1432, 1339, 1239, 1191, 1155, 1068, 1035, 919, 870, 743, 694 cm–1; 1H
NMR (400 MHz, DMSO-d6) δ 2.82 (s, 3H, MeN), 3.10–3.20 (m, 2H, СH2), 3.73 (s, 3H, MeO), 4.51 (d,
J = 13.6 Hz, 1H, CHH), 4.58 (d, J = 13.6 Hz, 1H, CHH), 5.03–5.09 (m, 1H, СH), 6.81 (ddd, J = 8.1,
2.3, 0.8 Hz, 1H, H-4'), 6.89–6.93 (m, 2H, H-2', H-6'), 7.05 (td, J = 7.4, 0.9 Hz, 1H, H-5/6), 7.12 (td, J =
7.5, 1.0 Hz, 1H, H-6/5), 7.23 (t, J = 8.1 Hz, 1H, H-5'), 7.42 (d, J = 8.0 Hz, 1H, H-4/7), 7.60 (d, J = 2.4
Hz, 1H, H-2), 7.74 (d, J = 7.9 Hz, 1H, H-7/4), 11.51 (s, 1H, NH); 13C NMR (100 MHz, DMSO-d6) δ
50.7, 55.1, 60.0, 65.0, 67.1, 102.5, 111.5, 112.0, 113.2, 118.0, 118.5, 119.7, 121.7, 127.6, 129.2, 129.5,
136.1, 143.6, 159.3, 164.4. Anal. Calcd for C19H22N2O2⋅(CO2H)2⋅H2O: C, 60.28; H, 6.26; N, 6.69.
Found: C, 60.42; H, 6.13; N, 6.55.
2-Methyl-4-phenyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole (6a). The crude product 6a was dissolved
in warm toluene (3.5 mL) and diluted with hexane (13 mL). The mixture was cooled to 0 °C and
filtered. The mother liquid was evaporated in vacuo and the residue was recrystallized from MeOH (by
cooling in a fridge). Colourless crystals, yield 54% (from 7a), 30% (from 1a) mp 89–93 °C (MeOH). IR
(ATR): 3392, 3145, 3055, 3027, 2965, 2937, 2870, 2845, 2784, 2743, 1622, 1598, 1492, 1451, 1349,
1326, 1307, 1237, 1225, 1159, 1148, 1121, 1098, 1075, 1052, 1031, 1008, 974, 736, 697 cm–1; 1H NMR
(400 MHz, DMSO-d6) δ 2.40 (s, 3H, MeN), 2.62 (dd, J = 11.3, 6.2 Hz, 1H, 3-CHH), 2.98 (dd, J = 11.3,
5.2 Hz, 1H, 3-CHH), 3.58 (d, J = 13.6 Hz, 1H, 1-CHH), 3.67 (d, J = 13.6 Hz, 1H, 1-CHH), 4.25 (t, J =
5.5 Hz, 1H, H-4), 6.94 (t, J = 7.4 Hz, 1H, H-7/8), 7.00 (t, J = 7.5 Hz, 1H, H-8/7), 7.19–7.25 (m, 4H, H-
6/9, Ph), 7.27–7.32 (m, 2H Ph), 7.38 (d, J = 7.7 Hz, 1H, H-9/6), 10.56 (s, 1H, NH); 13C NMR (101
MHz, DMSO-d6) δ 40.9, 45.6, 51.7, 61.7, 108.8, 111.3, 117.6, 118.6, 120.8, 125.4, 126.8, 128.47,
128.54, 134.2, 136.5, 143.1. Anal. Calcd for C18H18N2: C, 82.41; H, 6.92; N, 10.68. Found: C, 82.23; H,
6.76; N, 10.69.
4-(4-Bromophenyl)-2,5-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrogen oxalate (6c). The
crude product was chromatographed on an SiO2 column (CH2Cl2/MeOH, 100:3). The low melting free
base obtained was dissolved in dry acetone and converted into the hydrogen oxalate salt by treatment
with a solution of oxalic acid (0.09 g, 1.0 mmol) in dry acetone, then diluted with dry Et2O. After
filtration and washing with Et2O, the salt was dried in vacuo on a rotary evaporator at 50 °C for 90 min.
Light yellow powder, yield 38%, mp 179–183 °C. IR (ATR): 2960, 2879, 2697, 2590, 1717, 1605,
1487, 1472, 1425, 1404, 1354, 1324, 1252, 1184, 1137, 1087, 1014, 956, 818, 752, 700 cm–1; 1H NMR
(400 MHz, DMSO-d6) δ 2.84 (s, 3H, MeN), 3.23 (s, 3H, MeN), 3.33 (dd, J = 11.3, 8.5 Hz, 1H, 3-CHH),
3.72 (dd, J = 11.3, 5.4 Hz, 1H, 3-CHH), 4.36 (d, J = 14.0 Hz, 1H, 1-CHH), 4.44 (d, J = 14.0 Hz, 1H, 1-
CHH), 4.75 (br t, J = 6.0 Hz, 1H, H-4), 7.09 (t, J = 7.3 Hz, 1H, H-7/8), 7.15–7.24 (m, 3H, H-2′, H-6′, H-
8/7), 7.39 (d, J = 8.1 Hz, 1H, H-6/9), 7.53 (d, J = 7.8 Hz, 1H, H-9/6), 7.57 (d, J = 7.8 Hz, 2H, H-3′, H-
5′); 13C NMR (101 MHz, DMSO-d6) δ 30.2, 37.1, 42.5, 50.2, 57.9, 104.9, 109.6, 117.9, 119.4, 120.7,
121.8, 124.1, 130.5, 131.8, 132.6, 137.3, 139.3, 163.8. Anal. Calcd for C19H19BrN2⋅(CO2H)2⋅0.5H2O: C,
10